Trastuzumab deruxtecan (T-DXd; DS-8201) combinations in patients with HER2-positive advanced or metastatic breast cancer: A phase 1b/2 open-label, multicenter, dose-finding and dose-expansion study (DESTINY-Breast07) Meeting Abstract
| Authors: | Andre, F.; Hamilton, E.; Loi, S.; Schmid, P.; Yu, T.; Lu, S.; Boston, S.; D'Cruz, C.; Herbolsheimer, P.; Jhaveri, K. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd; DS-8201) combinations in patients with HER2-positive advanced or metastatic breast cancer: A phase 1b/2 open-label, multicenter, dose-finding and dose-expansion study (DESTINY-Breast07) |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700038 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-OT-03-04 |
| Notes: | Meeting Abstract: OT-03-04 -- Source: Wos |
